Ledger.Open graph →
SEC Form D · Amendment · filed February 9, 2017

Tarveda Therapeutics, Inc

Offering
$38.0M
Sold
$38.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Jeffrey Bisberg · Austin, TXExecLee Ainslie Iii · Dallas, TXDirectorWilliam Adams · San Francisco, CADirector · PromoterBarry Fernando · PHOENIX, AZExec · DirectorMichael D. Weinberg · Dallas, TXDirectorDaniel Spinner · Greenwich, CTDirectorJohn S. Koudounis · Naperville, ILExec · Director · PromoterFreshun D. Flowers · Tuscaloosa, ALDirectorJames J. Barrett · Watertown, MADirectorThomas Shandell · Greenwich, CTDirectorAndrew J. Fromkin · Watertown, MAExec · DirectorElizabeth A. Dickman · Amston, CTDirectorOmid C. Farokhzad · Watertown, MADirector · PromoterFrank C. Torti · Watertown, MADirectorNilesh C. Kumar · Watertown, MADirectorThomas E. Herman · Naperville, ILDirectorGregory S. Oberholtzer · Chicago, ILDirector · PromoterTheodore Haig · PHOENIX, AZDirectorEdwin M. Kania · Watertown, MADirectorDavid Hirschfeld · PHOENIX, AZExec · Director · PromoterAymeric S. Sallin · Watertown, MADirectorMark Phelps · PHOENIX, AZDirectorDennis C. Ausiello · Watertown, MADirectorBrian A. Meyer · New York, NYDirectorJustin Jory · San Francisco, CAExecRichard C. Wooster · Watertown, MAExecAndrew Saltoun · San Francisco, CAExec · DirectorNancy P. Carlson · Dallas, TXDirectorRobert S. Langer · Watertown, MADirector · PromoterLeila C. Alland · Watertown, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗